查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950582

血液採集管生產線市場（按產品類型、添加劑、材料類型、最終用戶和應用分類），全球預測，2026-2032年

Blood Collection Tube Production Line Market by Product Type, Additive, Material Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年血液採集管生產線市場價值為 9.1436 億美元，預計到 2026 年將成長至 9.9537 億美元，預計到 2032 年將達到 17.2847 億美元，複合年成長率為 9.52%。

關鍵市場統計數據
基準年 2025 9.1436億美元
預計年份：2026年 9.9537億美元
預測年份 2032 17.2847億美元
複合年成長率 (%) 9.52%

在不斷變化的臨床需求、尖端材料和日益嚴格的生產監管下，如何定位採血管生產線的戰略地位

血液採集管生產線在臨床診斷、檢查室工作流程和醫療器材製造的交會點佔據著至關重要的地位。檢測技術的快速發展和檢查室處理容量要求的不斷變化，使得採血管的可靠性、輔料相容性和生產擴充性變得日益重要。隨著臨床檢查室和醫院對分析前品質的持續性要求，製造商必須調整其生產流程以適應不斷變化的檢體處理標準，同時在整個自動化和人工組裝過程中保持嚴格的污染控制。

自動化技術的應用、材料創新以及日益嚴格的監管正在重塑臨床和科學研究市場的採血管生產策略。

血液採集管製造業正經歷變革性的轉變，這主要得益於技術進步、日益完善的監管以及實驗室醫學不斷提高的期望。自動化和機器人技術不再是可有可無的附加功能，而是成為實現穩定灌裝量、精確添加劑分配和污染控制的核心基礎技術。因此，製造商正在投資模組化生產架構，以便快速重新配置為單管和多管規格，以及真空和非真空產品線。

探討關稅調整對採購決策、製造地和供應鏈韌性的營運和策略影響

近期影響貿易流量的關稅調整為生產計畫、籌資策略和成本透明度帶來了新的考量。對於依賴跨境採購原料、瓶蓋和特殊塑膠的製造商而言，關稅波動加劇了供應商多元化和近岸外包評估的必要性。為此，許多採購團隊正在進行供應商韌性評估，尋找合格的替代供應商，並洽談長期契約，以確保原料供應的可靠性和品質。

將產品類型、添加劑化學、材料選擇、最終用戶背景和應用需求納入有針對性的生產線設計和品質策略中。

市場區隔洞察揭示了營運和產品開發的優先事項，這些事項應指南生產和商業化策略。根據產品類型，市場分為非真空和真空兩類，其中非真空類還包括注射器管和帶翼輸液管等，而真空類則包括單管和多管配置。這種產品層面的差異決定了不同的生產線佈局、無菌控制和自動化方案，以確保各種採集方式下性能的可靠性。

區域監管複雜性、需求特徵和製造業生態系統如何影響全球區域的生產重點和市場進入策略

區域趨勢對生產計畫、分銷策略和監管準備工作有顯著影響。在美洲地區，快速診斷結果和健全的機構採購框架仍然至關重要，尤其強調供應可靠性、完善的品質系統和本地技術支援。因此，面向該地區的製造商正優先發展區域分銷中心，建立本地無菌保證體系，並開發響應迅速的售後支援機制。

高性能採血管生產商的特點是：整合的生產技術、價值鏈協調以及增值客戶支援服務。

領先的採血管生產商將無菌生產、精密計量和添加劑化學方面的深厚專業知識與嚴格的品管和供應鏈整合相結合。市場領先的營運商通常強調垂直整合的能力，涵蓋聚合物擠出或玻璃加工、瓶蓋和瓶塞採購、添加劑配方控制以及檢驗的自動化填充和密封流程。這些整合能力減少了交接環節，降低了污染風險，並簡化了合規文件流程。

為製造商提供一套優先且切實可行的步驟，以提高生產靈活性、確保供應連續性、確保輔料相容性和符合監管要求。

行業領導者應優先考慮將卓越營運與市場應對力相結合的實際措施。首先，採用模組化自動化技術對生產線進行現代化改造，使其能夠同時適應單管和多管規格，並實現真空和非真空產品之間的快速切換。這既能提高生產效率，又能滿足實驗室不斷變化的需求，並在嚴格的檢驗通訊協定下維持產品品質。

採用穩健的混合方法研究途徑，結合相關人員訪談、工廠層級的檢驗和二手證據三角驗證，確保研究結果具有可操作性和檢驗。

我們的研究途徑結合了初步研究和與產業相關人員的嚴格二次檢驗，以建構對生產動態和策略重點的全面理解。初步調查方法包括對製造主管、品質保證負責人、採購經理和實驗室主任進行結構化訪談，以了解實際營運中的限制、技術採用的理由和採購行為。這些定性見解輔以工廠層級的訪談，以揭示生產線配置、無菌工作流程和自動化應用模式。

全面闡述整合製造卓越性、監管靈活性和以客戶為中心的創新如何定義採血管生產中的競爭優勢

總之，採血管生產線面臨技術、監管和供應鏈等多重壓力，需要進行有針對性的調整。投資於模組化自動化、精密添加劑計量系統和多元化採購的製造商將更有能力滿足診斷檢查室和醫院的複雜需求。同時，靈活的合規策略以及能夠維持服務水準的本地化生產或分銷解決方案，對於應對區域法規和不斷變化的關稅至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的採血管生產線市場

  • 非真空型
    • 注射器導管
    • 帶翼輸液管
  • 真空型
    • 單管
    • 多管

第9章 添加劑在血液採集管生產線市場的應用

  • 檸檬酸鹽
    • 緩衝檸檬酸鹽
    • 未添加檸檬酸鹽
  • 乙二胺四乙酸
    • K2 EDTA
    • K3 EDTA
  • 肝素
    • 鋰肝素
    • 肝素鈉

第10章 依材料類型分類的採血管生產線市場

  • 玻璃
  • 塑膠

第11章 依最終用戶分類的採血管生產線市場

  • 診斷檢查室
  • 醫院

第12章 依應用分類的採血管生產線市場

  • 臨床
  • 研究

第13章 各地區血液採集管生產線市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 血液採集管生產線市場（依集團分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國血液採集管生產線市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國採血管生產線市場

第17章 中國採血管生產線市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Danaher Corporation
  • FL Medical Srl
  • Fresenius SE & Co. KGaA
  • Greiner Bio-One International GmbH
  • Haemonetics Corporation
  • McKesson Corporation
  • Medline Industries, Inc.
  • Nipro Corporation
  • Roche Holding AG
  • Sarstedt AG & Co. KG
  • Siemens Healthineers AG
  • Smiths Medical
  • Terumo Corporation
Product Code: MRR-4F7A6D4FD8F8

The Blood Collection Tube Production Line Market was valued at USD 914.36 million in 2025 and is projected to grow to USD 995.37 million in 2026, with a CAGR of 9.52%, reaching USD 1,728.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 914.36 million
Estimated Year [2026] USD 995.37 million
Forecast Year [2032] USD 1,728.47 million
CAGR (%) 9.52%

Framing the strategic role of blood collection tube production lines amid evolving clinical requirements advanced materials and heightened manufacturing scrutiny

The blood collection tube production line occupies a critical position at the intersection of clinical diagnostics, laboratory workflows, and medical manufacturing. Rapid advances in assay technologies and shifting laboratory throughput requirements have elevated the importance of tube reliability, additive compatibility, and manufacturing scalability. As clinical laboratories and hospitals seek consistent pre-analytical quality, producers must align their operations with evolving specimen handling standards while maintaining stringent contamination control across automated and manual assembly processes.

In recent years, manufacturing strategy has pivoted from purely volume-driven models toward integrated value propositions that emphasize traceability, closed-system processing, and regulatory alignment. Concurrently, material innovation and additive chemistry have introduced both opportunities and complexities for production engineers who need to balance manufacturability with biochemical stability. Consequently, operations leaders are re-evaluating facility layouts, supplier portfolios, and quality assurance frameworks to sustain product integrity and meet the growing diversity of clinical and research applications.

This introduction frames the broader themes that determine competitive positioning in the blood collection tube domain, including supply chain resilience, process automation, and cross-functional coordination between quality, production, and regulatory teams. It sets the stage for a deeper exploration of transformational shifts and strategic responses across the remainder of the report.

How automation adoption material innovation and regulatory tightening are reshaping production strategies for blood collection tubes across clinical and research markets

The landscape for blood collection tube production is experiencing transformative shifts driven by technological advances, regulatory refinement, and heightened expectations from laboratory medicine. Automation and robotics are no longer optional enhancements but central enablers of consistent fill volumes, precise additive dispensation, and contamination control. As a result, manufacturers are investing in modular production architectures that allow rapid reconfiguration for monotube and multitube formats and for accommodating both vacuum and non-vacuum product lines.

Parallel to automation, material substitution towards high-performance plastics is accelerating because of breakage concerns, cost dynamics, and improvements in optical and chemical compatibility. This transition has implications for sealing technologies, sterilization protocols, and adhesive chemistries used in cap assemblies. Additionally, the refinement of additive chemistries, including buffered citrate formulations and optimized EDTA variants, is shaping pre-analytical stability requirements and placing new demands on dosing accuracy during production.

Regulatory expectations are tightening in many jurisdictions, increasing emphasis on traceability, bioburden control, and validation of analytical compatibility. Consequently, manufacturers must integrate enhanced quality systems and demonstrate cohesive product dossiers to satisfy laboratory procurement criteria. Taken together, these shifts require manufacturers to harmonize engineering investments with cross-disciplinary expertise in material science, chemistry, and regulatory affairs to maintain competitiveness and clinical trust.

Navigating the operational and strategic consequences of evolving tariff regimes that influence sourcing decisions manufacturing footprint and supply chain resilience

Recent tariff adjustments affecting trade flows have introduced new considerations for production planning, sourcing strategies, and cost transparency. For manufacturers that rely on cross-border procurement of raw materials, caps, or specialized plastics, tariff shifts have elevated the need for supplier diversification and nearshoring evaluations. In response, many procurement teams are conducting supplier resilience assessments, identifying alternate qualified vendors, and negotiating longer-term agreements to stabilize input availability and quality.

Tariff-driven pressures have also influenced decisions about where to locate specific manufacturing steps. Some firms are consolidating high-value, precision operations such as additive filling and sterile assembly closer to end markets to mitigate compliance complexity and reduce exposure to trade policy volatility. Conversely, commodity-intensive stages remain candidates for regional low-cost centers provided quality and logistics can be assured. These strategic redistributions affect lead times, inventory strategies, and the design of regional distribution networks.

Importantly, tariff-induced changes are prompting more rigorous cost-to-serve analyses that incorporate customs duties, inland logistics, and regulatory clearance lead times. Companies are therefore investing in cross-functional scenario planning that aligns procurement, manufacturing, and commercial functions to preserve product availability and maintain pricing transparency for institutional buyers.

Translating product type additive chemistry material selection end-user context and application needs into targeted production line design and quality strategies

Insight into market segmentation reveals operational and product development priorities that should inform manufacturing and commercialization strategies. Based on product type, the market is studied across Non Vacuum and Vacuum, with Non Vacuum further encompassing Syringe Tube and Winged Infusion Tube variations and Vacuum including Monotube and Multitube configurations; this product-level differentiation drives distinct production line layouts, sterility controls, and automation profiles to ensure reliable performance across collection modalities.

Based on additive, the market is studied across Citrate, Edta, and Heparin; within these categories, the Citrate segment is further studied across Buffered Citrate and Plain Citrate, EDTA is examined as K2 EDTA and K3 EDTA variants, and Heparin is considered in Lithium Heparin and Sodium Heparin forms. These additive distinctions compel precise dosing systems and validated compatibility testing to prevent assay interference. Based on material type, the market is studied across Glass and Plastic, which has direct implications for breakage risk, sterilization method selection, and sealing technologies.

Based on end user, the market is studied across Diagnostic Laboratory and Hospital settings, each with its own procurement cadence, quality expectations, and batch size preferences. Based on application, the market is studied across Clinical and Research uses, where clinical applications prioritize regulatory compliance and batch traceability, and research applications may require niche formulations and smaller lot flexibility. Integrating these segmentation dimensions into product roadmaps and production planning enables manufacturers to optimize capacity allocation and validation strategies for diverse customer needs.

How regional regulatory complexity demand profiles and manufacturing ecosystems shape production priorities and market access strategies across global territories

Regional dynamics exert a strong influence on production planning, distribution strategies, and regulatory readiness. The Americas region continues to emphasize rapid diagnostic turnaround and strong institutional procurement frameworks, which place a premium on supply reliability, documented quality systems, and local technical support. Consequently, manufacturers targeting this geography prioritize regional distribution hubs, validated local sterility assurances, and responsive after-sales service capabilities.

Europe, Middle East & Africa presents a complex regulatory mosaic with heterogeneous laboratory standards and procurement practices; this necessitates adaptable compliance strategies and region-specific dossier development. Manufacturers operating in this geography must maintain flexible certification approaches and localized regulatory expertise to navigate diverse market entry requirements while optimizing logistics for both urban medical centers and remote diagnostic facilities.

Asia-Pacific encompasses a spectrum of market maturities and manufacturing capabilities, making it both a major production base and a rapidly growing demand center. In this region, investments in cost-effective automation, scalable sterile packaging lines, and strategic supplier partnerships can unlock operational advantages. Given these regional distinctions, a differentiated market approach that balances centralized quality governance with localized operational execution will yield the most resilient commercial outcomes.

What distinguishes high-performing blood collection tube manufacturers including integrated production expertise supply chain coordination and value-added customer support services

Companies that lead in blood collection tube production combine deep expertise in sterile manufacturing, precision dosing, and additive chemistry with rigorous quality management and supply chain integration. Market-leading operations commonly emphasize vertically coordinated capabilities that span polymer extrusion or glass conversion, cap and stopper sourcing, additive formulation control, and validated automated filling and sealing processes. These integrated capabilities reduce handoffs, lower contamination risk, and simplify compliance documentation.

Strategic differentiation also arises from investments in innovation around additive stability and specialized tube formats such as multitube assemblies or winged infusion compatible designs. In addition, service-oriented offerings that include technical support for assay compatibility, lot-specific certificates of analysis, and rapid regulatory response enhance customer retention among diagnostic laboratories and hospital systems. Contract manufacturing partnerships remain a core industry model, enabling brand owners to scale without duplicating capital-intensive sterile facilities while maintaining rigorous oversight through supplier qualification programs.

Finally, partnerships with component suppliers, automation vendors, and regulatory consultants form an ecosystem that supports accelerated product introductions and lifecycle management. For companies seeking to enhance competitive positioning, focusing on traceability, supply reliability, and collaborative innovation will be decisive in winning institutional procurement and research partnerships.

A prioritized set of practical steps for manufacturers to augment production agility secure supply continuity and ensure additive compatibility and regulatory readiness

Industry leaders should prioritize a set of actionable moves that bridge operational excellence with market responsiveness. First, modernize production lines with modular automation that can accommodate both monotube and multitube formats and that enables quick changeovers for vacuum and non-vacuum products to meet dynamic laboratory demands. Linking these investments to rigorous validation protocols will preserve product integrity while improving throughput.

Second, diversify supplier networks for critical inputs including caps, stoppers, and specialty polymers, and qualify regional second-source partners to reduce exposure to trade disruptions and tariff impacts. Parallel investments in advanced inventory analytics and demand-sensing capabilities will reduce lead-time risk and align production cycles with hospital and diagnostic lab procurement patterns. Third, strengthen additive handling and dosing systems to ensure precise delivery of buffered citrate, EDTA variants, and heparin formulations, coupled with robust stability and compatibility testing to satisfy clinical users.

Lastly, embed regulatory intelligence into early-stage design decisions, and develop localized regulatory dossiers for target regions to accelerate market entry. Implementing these recommendations in a phased manner-starting with pilot lines and targeted supplier qualification-can deliver measurable improvements in resilience, compliance readiness, and customer satisfaction.

A robust mixed-methods research approach combining stakeholder interviews plant-level validation and secondary evidence triangulation to ensure actionable and verifiable insights

The research approach combines primary engagement with industry stakeholders and rigorous secondary validation to construct a defensible view of production dynamics and strategic priorities. Primary methods include structured interviews with manufacturing leaders, quality assurance professionals, procurement managers, and laboratory directors to capture lived operational constraints, technology adoption rationales, and procurement behaviors. These qualitative inputs are complemented by plant-level interviews that illuminate line configurations, sterility workflows, and automation implementation patterns.

Secondary validation involves reviewing industry standards, regulatory guidance, and technical literature to corroborate primary findings, while ensuring that data is contextualized within current manufacturing and clinical practices. Data triangulation is performed by cross-referencing supplier capabilities, component specifications, and observable technology deployments from multiple independent sources. Quality assurance for the research process includes iterative fact checks with subject-matter experts, consistency reviews across related datasets, and documentation of data provenance for traceability.

Finally, the methodology emphasizes actionable synthesis by translating technical insights into operational guidance for production planners, procurement teams, and regulatory affairs groups, ensuring the research is both evidence-based and directly applicable to decision-making cycles.

Summative perspective on how integrated manufacturing excellence regulatory agility and customer-focused innovation will determine competitive advantage in blood collection tube production

In conclusion, the blood collection tube production line is confronting a confluence of technological, regulatory, and supply chain pressures that necessitate deliberate operational adaptation. Manufacturers that invest in modular automation, precise additive dosing systems, and diversified sourcing will be better positioned to meet the nuanced demands of diagnostic laboratories and hospitals. At the same time, regional regulatory complexity and tariff-induced shifts require agile compliance strategies and localized manufacturing or distribution solutions to maintain service levels.

Strategically, the most resilient producers will integrate material science expertise with rigorous quality systems and a service-oriented commercial approach that supports laboratory users through assay compatibility and post-market support. By aligning production design with segmentation nuances-from vacuum versus non-vacuum formats to additive chemistry and end-user requirements-companies can reduce time-to-market for new formats and preserve specimen integrity across clinical and research applications.

Taken together, these factors point toward a path where operational excellence and customer-centric innovation jointly determine competitive advantage in the blood collection tube space.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Tube Production Line Market, by Product Type

  • 8.1. Non Vacuum
    • 8.1.1. Syringe Tube
    • 8.1.2. Winged Infusion Tube
  • 8.2. Vacuum
    • 8.2.1. Monotube
    • 8.2.2. Multitube

9. Blood Collection Tube Production Line Market, by Additive

  • 9.1. Citrate
    • 9.1.1. Buffered Citrate
    • 9.1.2. Plain Citrate
  • 9.2. Edta
    • 9.2.1. K2 Edta
    • 9.2.2. K3 Edta
  • 9.3. Heparin
    • 9.3.1. Lithium Heparin
    • 9.3.2. Sodium Heparin

10. Blood Collection Tube Production Line Market, by Material Type

  • 10.1. Glass
  • 10.2. Plastic

11. Blood Collection Tube Production Line Market, by End User

  • 11.1. Diagnostic Laboratory
  • 11.2. Hospital

12. Blood Collection Tube Production Line Market, by Application

  • 12.1. Clinical
  • 12.2. Research

13. Blood Collection Tube Production Line Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Collection Tube Production Line Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Collection Tube Production Line Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Blood Collection Tube Production Line Market

17. China Blood Collection Tube Production Line Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Baxter International Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Cardinal Health, Inc.
  • 18.9. Danaher Corporation
  • 18.10. F.L. Medical S.r.l.
  • 18.11. Fresenius SE & Co. KGaA
  • 18.12. Greiner Bio-One International GmbH
  • 18.13. Haemonetics Corporation
  • 18.14. McKesson Corporation
  • 18.15. Medline Industries, Inc.
  • 18.16. Nipro Corporation
  • 18.17. Roche Holding AG
  • 18.18. Sarstedt AG & Co. KG
  • 18.19. Siemens Healthineers AG
  • 18.20. Smiths Medical
  • 18.21. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SYRINGE TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SYRINGE TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SYRINGE TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY WINGED INFUSION TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY WINGED INFUSION TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY WINGED INFUSION TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MONOTUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MONOTUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MONOTUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MULTITUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MULTITUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MULTITUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY BUFFERED CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY BUFFERED CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY BUFFERED CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PLAIN CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PLAIN CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PLAIN CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY K2 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY K2 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY K2 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY K3 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY K3 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY K3 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY LITHIUM HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY LITHIUM HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY LITHIUM HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SODIUM HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SODIUM HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SODIUM HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 212. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 213. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 215. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 223. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 224. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 227. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 228. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY NON VACUUM, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY VACUUM, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY CITRATE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY HEPARIN, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BLOOD COLLECTION TUBE PRODUCTION LINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)